Patents for A61P 19 - Drugs for skeletal disorders (81,981)
02/1999
02/04/1999WO1999005111A1 Novel tetrazole derivatives
02/04/1999WO1999005107A1 Vitronectin receptor antagonist
02/04/1999WO1999005096A2 Urokinase inhibitors
02/04/1999WO1999004794A1 Cyclic amine modulators of chemokine receptor activity
02/04/1999WO1999004773A2 Method for inhibiting bone resorption
02/04/1999CA2349744A1 Inhibition bone resorption
02/04/1999CA2349733A1 Inhibition bone resorption
02/04/1999CA2298930A1 Pharmaceuticals for modulating hormone responsiveness
02/04/1999CA2298053A1 Novel estrogen receptor .beta. and isoforms
02/04/1999CA2297923A1 Novel tetrazole-substituted 6-phenyl-pheanathridines as pde inhibitors
02/04/1999CA2297910A1 Vitronectin receptor antagonist
02/04/1999CA2297907A1 Human estrogen receptor beta
02/04/1999CA2296314A1 Cyclic amine modulators of chemokine receptor activity
02/04/1999CA2294300A1 Urokinase inhibitors
02/03/1999EP0894863A1 A YAK-1 related serine/threonine protein kinase-HTLAR33
02/03/1999EP0894855A2 Human I kappa B-beta transcription factor
02/03/1999EP0894854A2 A novel splicing variant of the epstein-barr virus-induced g-protein coupled receptor
02/03/1999EP0894093A2 Soluble tachykinin antagonists, the preparation and use thereof
02/03/1999EP0894084A1 Cinnamic acid derivatives and their use as integrin antagonists
02/03/1999EP0793649B1 18,19-dinor-vitamin d compounds
02/03/1999CN1207049A Skin-adhering pharmaceutical preparation, in particular transdermal therapeutic system for the release of 17-'beta'-estradiol to the human organism
02/03/1999CN1207044A Cyclosporin-containing soft capsule preparations
02/03/1999CN1206607A Medicine for curing bone fracture
02/03/1999CN1206603A Guyanling plaster (for osteitis) preparation process
02/02/1999US5866702 Purine inhibitors of cyclin dependent kinase 2
02/02/1999US5866568 Heterocyclic compounds
02/02/1999US5866556 Pyridinylbisphosphonates for use as a therapeutical agent
02/02/1999US5866540 Cyclic adhesion inhibitors
02/02/1999US5866364 Recombinant bone morphogenetic protein heterodimers
01/1999
01/28/1999WO1999003996A1 Modified dorsal tissue affecting factor and compositions
01/28/1999WO1999003878A2 Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis
01/28/1999WO1999003837A1 2-substituted imidazoles useful in the treatment of inflammatory diseases
01/28/1999WO1999003828A1 Dihomo-seco-cholestanes with two unsaturated bones in the side chain
01/28/1999WO1999003826A2 Metalloproteinase inhibitors
01/28/1999WO1999003516A2 Semi-interpenetrating polymer networks
01/28/1999WO1998049138A3 Vitamin d3 analogs with bis c-20 side chains
01/28/1999WO1998046632A3 Inhibitors for urokinase receptor
01/28/1999CA2296145A1 Dihomo-seco-cholestanes with two unsaturated bonds in the side chain
01/28/1999CA2295021A1 2-substituted imidazoles useful in the treatment of inflammatory diseases
01/28/1999CA2237155A1 A yak-1 related serine/threonine protein kinase-htlar33
01/27/1999EP0893503A2 Regulator protein from Staphylococcus aureus
01/27/1999EP0893499A2 Tetracycline resistance protein from Staphylococcus aureus
01/27/1999EP0893498A2 cDNA clone MY1 that encodes a novel human 7-transmembrane receptor
01/27/1999EP0892809A1 Fhit proteins and nucleic acids and methods based thereon
01/27/1999EP0892791A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
01/27/1999EP0892642A1 Use in a composition of an extract of at least one labiate
01/27/1999CN1206422A Growth-hormone secretagogues
01/27/1999CN1206405A Imides as PDE III, PDE IV and TNF inhibitors
01/27/1999CN1206348A Extracts of shark cartilage
01/27/1999CN1041797C Tablets with improved bioavailability of active material clodronic acid
01/26/1999US5864036 Substituted imidazole compounds
01/26/1999US5863931 Amidino derivatives and their use as nitric oxide synthase inhibitors
01/26/1999US5863780 A polynucleotide sequence encodes human protein kinase polypeptide; culture product
01/26/1999US5863766 Isolated, pure polynucleotide encoding a polypeptide for treating vesicle trafficking, immunological, and neoplastic disorders.
01/26/1999CA2166692C Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
01/25/1999CA2238664A1 Novel regulator
01/25/1999CA2238655A1 Cdna clone my1 that encodes a novel human 7-transmembrane receptor
01/23/1999CA2238674A1 Novel tetracycline resistance protein
01/23/1999CA2238665A1 Novel reductase
01/21/1999WO1999002679A1 Frazzled nucleotide sequences, expression products, compositions and uses
01/21/1999WO1999002666A2 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses
01/21/1999WO1999002654A1 Isolation of bone and cartilage precursor cells
01/21/1999WO1999002547A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
01/21/1999WO1999002539A1 Diphosphonic acid salts for the treatment of osteoporosis
01/21/1999WO1999002514A2 Epothilone derivatives
01/21/1999CA2303210A1 Salts of diphosphonic acids and amino-alcohols for the treatment of osteoporosis
01/21/1999CA2295935A1 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses
01/20/1999EP0892057A2 Response regulator
01/20/1999EP0892051A2 CDNA Clone heoad54 that encodes a human 7 transmembrane receptor
01/20/1999EP0892050A2 Human HFIZG53
01/20/1999EP0891375A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity
01/20/1999EP0891372A1 Growth factor htter36
01/20/1999EP0891364A1 Calixpyrroles, calixpyridinopyrroles and calixpyridines
01/20/1999EP0891346A1 Dihydrobenzofuran compounds useful as anti-inflammatory agents
01/20/1999EP0891332A1 6-phenylpyridyl-2-amine derivatives
01/20/1999EP0891326A1 Novel vitamin d analogues
01/20/1999EP0891325A1 Para-substituted phenylpropanoic acid derivatives as integrin antagonists
01/20/1999EP0630245B1 Protein kinase c inhibitor
01/20/1999CN1205328A Sulfonylaminocarboxylic acids
01/20/1999CN1205222A Medicinal liquor for treating rheumatism and atrophic arthritis
01/20/1999CN1205205A Pyrazolopyridine compound and processes for preparation thereof
01/19/1999US5861510 Antiarthritic agents, antiulcer agents, restenosis, oral diseases
01/19/1999US5861438 Combination therapy to prevent bone loss parathyroid hormone and estrogen agonists
01/19/1999US5861386 Prevention of loss of bone mass or bone minerals
01/18/1999CA2237043A1 Response regulator
01/14/1999WO1999001553A1 Murine and human cerberus-like proteins and compositions comprising them
01/14/1999WO1999001472A1 Cyclic azapeptides with angiogenic effect
01/14/1999WO1999001466A1 Secreted proteins and polynucleotides encoding them
01/14/1999WO1999001452A1 Novel cycloalkyl substituted imidazoles
01/14/1999WO1999001449A1 2-substituted 4,5-diaryl imidazoles
01/14/1999WO1999001428A1 Hydrazine derivatives
01/14/1999WO1999001164A1 Cloning pigs using donor nuclei from differentiated cells
01/14/1999WO1999001147A1 Method and product using sturgeon notochord for alleviating the symptoms of arthritis
01/14/1999WO1999001143A1 Cross-linked polysaccharide drug carrier
01/14/1999WO1999001136A1 Novel substituted imidazole compounds
01/14/1999WO1999001131A1 Novel substituted imidazole compounds
01/14/1999WO1999001130A1 Novel substituted imidazole compounds
01/14/1999CA2297181A1 Cyclic azapeptides
01/14/1999CA2295762A1 Novel cycloalkyl substituted imidazoles
01/14/1999CA2295294A1 Cloning pigs using donor nuclei from differentiated cells